NLVP
GEVA

New Leaf Venture Partners’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

New Leaf Venture Partners’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-24,379
Closed -$2.38M – 16
2015
Q1 		$2.38M Buy
+24,379
New +$2.58M 1.61% 11

New Leaf Venture Partners's GEVA Position: Q2 2015 in Review

New Leaf Venture Partners sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 24,379 shares — an estimated $2.38M sold.

New Leaf Venture Partners first reported a position in GEVA in Q1 2015 and held it in 1 quarter. The position peaked at $2.38M in Q1 2015. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • New Leaf Venture Partners reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • New Leaf Venture Partners sold 24,379 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $2.38M.
  • New Leaf Venture Partners first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q1 2015 and held it in 1 quarter.
  • New Leaf Venture Partners's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $2.38M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on New Leaf Venture Partners's 13F filing for Q2 2015, filed 14 Aug 2015.